Inspire Medical Systems, Inc. to Present at Piper Sandler 36th Annual Healthcare Conference
Inspire Medical Systems (NYSE: INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The presentation is scheduled for Tuesday, December 3, 2024, at 12:00 p.m. Eastern Time. Interested parties can access the presentation through a live webcast, with replays available for two weeks afterward on the company's investor website at investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), un'azienda tecnologica medica specializzata in soluzioni minimamente invasive per l'apnea ostruttiva del sonno, ha annunciato la sua partecipazione alla 36ª Conferenza Sanitaria Annuale di Piper Sandler. La presentazione è programmata per martedì 3 dicembre 2024, alle 12:00 p.m. ora orientale. Le parti interessate possono accedere alla presentazione tramite una diretta streaming, con repliche disponibili per due settimane successivamente sul sito web per investitori dell'azienda all'indirizzo investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), una empresa de tecnología médica especializada en soluciones mínimamente invasivas para la apnea obstructiva del sueño, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. La presentación está programada para el martes 3 de diciembre de 2024, a las 12:00 p.m. hora del Este. Las partes interesadas pueden acceder a la presentación a través de una transmisión en vivo, con repeticiones disponibles por dos semanas después en el sitio web de inversores de la empresa en investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), 폐쇄성 수면 무호흡증을 위한 최소 침습적 솔루션을 전문으로 하는 의료 기술 회사가 Piper Sandler 제36회 연례 의료 컨퍼런스에 참석한다고 발표했습니다. 발표는 2024년 12월 3일 화요일, 동부 표준시 기준으로 오후 12시에 예정되어 있습니다. 관심 있는 분들은 생중계를 통해 발표를 시청할 수 있으며, 이후 2주간 회사의 투자자 웹사이트인 investors.inspiresleep.com에서 재생이 가능합니다.
Inspire Medical Systems (NYSE: INSP), une entreprise de technologie médicale spécialisée dans les solutions mini-invasives pour l'apnée obstructive du sommeil, a annoncé sa participation à la 36e Conférence Annuelle de Santé de Piper Sandler. La présentation est prévue pour le mardi 3 décembre 2024, à 12h00 heure de l'Est. Les parties intéressées peuvent accéder à la présentation via un webinaire en direct, avec des rediffusions disponibles pendant deux semaines par la suite sur le site web des investisseurs de l'entreprise à l'adresse investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), ein Medizintechnikunternehmen, das sich auf minimalinvasive Lösungen für obstruktive Schlafapnoe spezialisiert hat, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler bekannt gegeben. Die Präsentation ist für Dienstag, den 3. Dezember 2024, um 12:00 Uhr Eastern Time angesetzt. Interessierte können die Präsentation über einen Live-Stream verfolgen, mit Wiederholungen, die zwei Wochen lang auf der Investorenseite des Unternehmens unter investors.inspiresleep.com verfügbar sind.
- None.
- None.
MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024.
Inspire is scheduled to present at 12:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here.
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When is Inspire Medical Systems (INSP) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Inspire Medical Systems' (INSP) presentation at the Piper Sandler Conference?
How long will the replay of Inspire Medical Systems' (INSP) Piper Sandler presentation be available?
What is the focus of Inspire Medical Systems' (INSP) business presentation?
